ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8,501 | 80.62396 | 1 |
female
| 1 | 3 | 3 |
MOSF w/Malig
|
ARF/MOSF
| 3 | 9 |
$11-$25k
| 100 | 5,328 | 3,825.4981 | 3,869.93945 | 29 |
white
| 39.09375 | 60 | 0.004 | 0 | 1 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 1 | 56 | 16.199219 | 96 | 13 | 36.09375 | null | 2.399902 | 0.799927 | 6.5 | 139 | null | 162 | 60 | 304 | null | null |
<2 mo. follow-up
| 4.129883 |
8,502 | 64.159 | 0 |
male
| 0 | 84 | 1,030 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 37 | 196,926 | 140,458.25 | 134,407.625 | 23.25 |
white
| 27.5 | 83 | 0.513916 | 0.397949 | 17 | 1 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 84 | 63 | 21.597656 | 104 | 10 | 37.89844 | 292 | 2.5 | 0.199982 | 4.5 | 133 | 7.399414 | 236 | 34 | 195 | null | null |
Coma or Intub
| 2.669922 |
8,503 | 71.20599 | 1 |
male
| 1 | 19 | 19 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 19 |
>$50k
| 41 | 81,716 | 57,042.6875 | 54,791.5938 | 45.666657 |
white
| 37.195313 | 69 | 0.127991 | 0.057999 | 1 | 0 | 0 |
metastatic
| 0.25 | 0.25 |
dnr after sadm
| 18 | 101 | 7.799805 | 107 | 22 | 35.5 | null | 3.699707 | 0.699951 | 1.299805 | 135 | null | 123 | 16 | 3,400 | null | 0 |
<2 mo. follow-up
| 0 |
8,504 | 76.01398 | 1 |
male
| 0 | 11 | 89 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 12 |
$25-$50k
| 0 | 8,210 | 5,734.2891 | 4,731.03906 | 10 |
white
| 20.097656 | 31 | 0.825928 | 0.715942 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 11 | 63 | 0.799927 | 124 | 32 | 40.29688 | null | null | null | 1 | 140 | null | 152 | 23 | 2,725 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,505 | 76.86499 | 1 |
male
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | null |
under $11k
| 37 | 34,265 | 22,998.5156 | 25,846.0469 | 35.5 |
white
| 28.398438 | 46 | 0.345947 | 0.22998 | 7 | 0 | 0 |
yes
| 0.75 | 0.75 |
dnr before sadm
| -6 | 70 | 5.299805 | 71 | 20 | 36.79688 | 257.125 | 4.199219 | 0.299988 | 0.899902 | 140 | 7.519531 | 105 | 7 | 3,400 | null | 5 |
<2 mo. follow-up
| 5 |
8,506 | 76.05695 | 1 |
female
| 0 | 7 | 468 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 7,822 | 5,231.5078 | 5,692.80859 | 8.5 |
white
| 20.097656 | 18 | 0.781982 | 0.710938 | 1 | 0 | 0 |
yes
| null | null |
no dnr
| 7 | 77 | 9.798828 | 64 | 24 | 35.29688 | null | 4.299805 | 0.799927 | 1.199951 | 137 | null | 123 | 23 | null | null | 6 | null | 6 |
8,507 | 58.65598 | 0 |
male
| 0 | 10 | 1,025 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 10 | null | 0 | 6,493 | 4,331.8125 | 4,826.31641 | 7 |
white
| 13.5 | 23 | 0.932983 | 0.886963 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 10 | 108 | 32.695313 | 122 | 28 | 36.19531 | 209.5 | 3 | 0.599976 | 0.799927 | 140 | 7.40918 | 210 | 25 | 2,000 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,508 | 42.66098 | 1 |
male
| 0 | 4 | 7 |
Colon Cancer
|
Cancer
| 1 | 10 |
>$50k
| 0 | 4,419 | 2,632.5547 | 1,728.67969 | 12 |
white
| 16.898438 | 14 | 0.85498 | 0.677979 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 4 | 63 | 4.099609 | 101 | 22 | 36.09375 | 296.25 | null | null | 0.799927 | 148 | 7.419922 | 139 | 11 | 570 | null | null |
<2 mo. follow-up
| 1.775147 |
8,509 | 49.37698 | 0 |
male
| 0 | 13 | 1,022 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 13 |
$25-$50k
| 41 | 24,837 | 17,625.0469 | 19,236.6719 | 23.5 |
white
| 29.796875 | 32 | 0.570923 | 0.459961 | 5 | 0 | 0 |
no
| 0.98 | 0.98 |
no dnr
| 13 | 105 | 10.699219 | 81 | 24 | 36.19531 | null | null | null | 1.599854 | 136 | null | 218 | 19 | 2,375 | null | 1 |
no(M2 and SIP pres)
| 1 |
8,510 | 58.81198 | 0 |
male
| 0 | 7 | 1,024 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 20 | null | 0 | 11,502 | 7,187.3828 | 7,626.59766 | 8 |
white
| 16 | 24 | 0.909912 | 0.848999 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 83 | 14.298828 | 70 | 28 | 36.59375 | 122.4375 | null | null | 1.199951 | 134 | 7.279297 | 220 | 21 | 2,750 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
8,511 | 44.79099 | 1 |
male
| 0 | 5 | 423 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 6,825 | 3,957.3223 | 1,819.3291 | 10 |
white
| 14.298828 | 8 | 0.796997 | 0.56897 | 1 | 0 | 0 |
metastatic
| 0.95 | 0.9 |
no dnr
| 5 | 67 | 16.097656 | 56 | 24 | 36.39844 | 207.5 | null | null | 2.099609 | 140 | 7.329102 | 110 | 61 | 1,600 | null | null |
no(M2 and SIP pres)
| 1.929199 |
8,512 | 57.80197 | 1 |
female
| 0 | 11 | 932 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1 | null | null | 0 | 8,502 | 5,531.3594 | 6,651.1875 | 20.5 |
white
| 21.296875 | 36 | 0.783936 | 0.653931 | 1 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 11 | 105 | 33 | 140 | 30 | 36.79688 | 220 | 3.299805 | 0.599976 | 1.099854 | 152 | 7.519531 | 169 | 38 | 1,300 | null | null | null | 2.643066 |
8,513 | 95.34796 | 1 |
male
| 0 | 4 | 574 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 10 |
$25-$50k
| 0 | 2,889 | 2,034.4414 | 1,931.69922 | 5 |
white
| 18.5 | 23 | 0.772949 | 0.637939 | 1 | 1 | 0 |
no
| 0.99 | 0.98 |
no dnr
| 4 | 96 | 6.699219 | 62 | 16 | 37.19531 | null | 3.599609 | 0.199982 | 1.399902 | 139 | null | 92 | 19 | 875 | null | null |
no(M2 and SIP pres)
| 3.210449 |
8,514 | 78.40399 | 1 |
female
| 0 | 11 | 34 |
Coma
|
Coma
| 1 | 12 |
under $11k
| 44 | 18,964 | 12,842.6953 | 13,325.2969 | 10.5 |
white
| 16.796875 | 23 | 0.562988 | 0.494995 | 1 | 0 | 0 |
no
| 0.3 | 0.1 |
dnr after sadm
| 4 | 110 | 9.798828 | 215 | 24 | 35.89844 | 261.875 | 3.399902 | 0.399963 | 0.699951 | 138 | 7.40918 | 219 | 11 | 1,050 | null | 0 |
<2 mo. follow-up
| 0 |
8,515 | 66.85596 | 0 |
female
| 0 | 17 | 1,019 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 30,742 | 21,348.7344 | 19,812.7969 | 14 |
hispanic
| 21.597656 | 30 | 0.74292 | 0.662964 | 7 | 0 | 0 |
yes
| 0.8 | 0.75 |
no dnr
| 17 | 109 | 1.099854 | 81 | 24 | 36.19531 | 292.5625 | 4 | 0.799927 | 1.099854 | 141 | 7.379883 | 209 | 24 | 700 | null | null |
no(M2 and SIP pres)
| 2.117676 |
8,516 | 68.862 | 1 |
male
| 0 | 39 | 200 |
MOSF w/Malig
|
ARF/MOSF
| 3 | 12 |
$25-$50k
| 37 | 64,543 | 42,614.5 | 44,507.9688 | 35.5 |
white
| 39.59375 | 81 | 0.058998 | 0.019997 | 1 | 0 | 0 |
metastatic
| 0.3 | 0.3 |
dnr after sadm
| 27 | 59 | 23.398438 | 120 | 28 | 35.59375 | 67.76562 | 2 | 1.099854 | 1.199951 | 148 | 7.25 | 237 | 37 | 2,900 | null | 1 |
no(M2 and SIP pres)
| 1 |
8,517 | 76.24097 | 0 |
female
| 0 | 7 | 1,017 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 5,039 | 3,335.2715 | 3,161.12891 | 3.5 |
white
| 14.199219 | 33 | 0.842896 | 0.74292 | 1 | 0 | 0 |
yes
| 0.9 | 0.9 |
no dnr
| 7 | 54 | 14.5 | 72 | 16 | 38.19531 | 237.5 | 2 | 1.599854 | 3.399902 | 132 | 7.329102 | 151 | 86 | 1,150 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,518 | 53.55197 | 1 |
female
| 0 | 8 | 36 |
Coma
|
Coma
| 1 | 12 |
$11-$25k
| 44 | 21,253 | 16,260.5625 | 18,439.3281 | 17.5 |
white
| 17.398438 | 11 | 0.68396 | 0.62793 | 1 | 0 | 0 |
yes
| 0.5 | 0.1 |
no dnr
| 8 | 38 | 10.398438 | 49 | 24 | 35.79688 | 156.25 | 3.099609 | 8.298828 | 3 | 135 | 7.269531 | 74 | 95 | 30 | null | 2 |
<2 mo. follow-up
| 2 |
8,519 | 58.62299 | 1 |
female
| 0 | 15 | 164 |
COPD
|
COPD/CHF/Cirrhosis
| 0 | 13 |
$11-$25k
| 0 | 14,096 | 9,527.4844 | 10,530.1484 | 10.666664 |
white
| 23.5 | 35 | 0.855957 | 0.762939 | 1 | 0 | 0 |
no
| 1 | 0.9 |
no dnr
| 15 | 72 | 16.296875 | 124 | 16 | 38.29688 | 316 | 2.199707 | 6.699219 | 0.899902 | 130 | 7.479492 | 171 | 2 | 4,660 | 0 | 0 |
adl>=4 (>=5 if sur)
| 0 |
8,520 | 91.96698 | 1 |
male
| 0 | 10 | 31 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 4 |
under $11k
| 0 | 6,512 | 4,440.8672 | 3,682.92969 | 5 |
white
| 24.5 | 32 | 0.67688 | 0.505981 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 61 | 52.398438 | 101 | 28 | 36.39844 | 266.625 | 4 | 0.799927 | 1.599854 | 129 | 7.449219 | 124 | 26 | 3,380 | null | 2 |
<2 mo. follow-up
| 2 |
8,521 | 70.20398 | 1 |
male
| 0 | 4 | 9 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 1,742 | 1,199.4209 | 1,106.15918 | 5 |
white
| 14.298828 | 27 | 0.899902 | 0.831909 | 1 | 0 | 0 |
no
| 0.7 | 0.5 |
dnr after sadm
| 2 | 125 | null | 114 | 20 | 36.5 | 242.84375 | 3.599609 | 0.5 | 1.5 | 129 | 7.40918 | 135 | 15 | 2,725 | null | null |
<2 mo. follow-up
| 1.901123 |
8,522 | 73.47595 | 1 |
male
| 0 | 8 | 277 |
Colon Cancer
|
Cancer
| 2 | null | null | 0 | 4,644 | 3,087.9258 | 2,881.76953 | 7 |
white
| 3.299805 | 12 | 0.929932 | 0.834961 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 8 | 115 | 8.099609 | 81 | 24 | 36.29688 | 208.6875 | 3.799805 | 0.199982 | 0.599976 | 135 | 7.329102 | 190 | 6 | 4,050 | null | null | null | 1.911133 |
8,523 | 67.146 | 0 |
male
| 0 | 9 | 1,011 |
CHF
|
COPD/CHF/Cirrhosis
| 6 | 11 | null | 0 | 6,888 | 4,779.3477 | 3,852.16992 | 11 |
white
| 24.398438 | 47 | 0.800903 | 0.677979 | 1 | 1 | 0 |
no
| 0.8 | 0.5 |
no dnr
| 9 | 41 | 7.199219 | 97 | 20 | 37.79688 | null | null | null | 10.199219 | 130 | null | 135 | 54 | 0 | 2 | 3 |
no(M2 and SIP pres)
| 3 |
8,524 | 35.978 | 1 |
female
| 1 | 32 | 32 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 123,597 | 76,373.9375 | 122,543.812 | 40.25 |
white
| 31.5 | 44 | 0.751953 | 0.67395 | 1 | 0 | 0 |
yes
| 0.85 | 0.25 |
dnr after sadm
| 28 | 114 | 14.298828 | 107 | 24 | 37.79688 | null | 2.699707 | 0.299988 | 6.599609 | 125 | null | 169 | 31 | 0 | null | 0 |
<2 mo. follow-up
| 0 |
8,525 | 78.65796 | 1 |
male
| 0 | 21 | 264 |
MOSF w/Malig
|
ARF/MOSF
| 2 | null | null | 0 | 51,280 | 33,954.9688 | 36,876.6875 | 20.333328 |
white
| 30.199219 | 40 | 0.480957 | 0.362976 | 3 | 1 | 0 |
yes
| null | null |
no dnr
| 21 | 63 | 19.199219 | 59 | 7 | 38.69531 | 150 | 2 | 0.5 | 2.299805 | 141 | 7.40918 | 113 | 33 | 1,670 | null | null | null | 2.404785 |
8,526 | 73.97894 | 1 |
female
| 0 | 20 | 562 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 8 | null | 26 | 13,754 | 9,171.4688 | 7,574.55859 | 7.333332 |
white
| 14.798828 | 10 | 0.840942 | 0.738892 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
dnr after sadm
| 1 | 63 | 5.399414 | 58 | 10 | 39.29688 | 152 | 2.899902 | 11.298828 | 0.799927 | 135 | 7.459961 | 168 | 10 | 750 | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
8,527 | 21.60199 | 0 |
female
| 0 | 64 | 1,010 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
$11-$25k
| 26 | 184,711 | 117,790.562 | 122,645.188 | 46.5 |
white
| 26.097656 | 40 | 0.802979 | 0.736938 | 15 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 64 | 115 | 14.199219 | 70 | 14 | 36.29688 | 242.84375 | 3.699707 | 0.5 | 3.599609 | 139 | 7.279297 | 247 | 80 | 1,900 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,528 | 83.02795 | 1 |
female
| 0 | 25 | 36 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 44 | 76,505 | 49,727.5938 | 51,341.3125 | 24.25 |
white
| 39 | 66 | 0.072998 | 0.025997 | 13 | 1 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 24 | 102 | 7.299805 | 60 | 24 | 35.69531 | 285.6875 | 3.399902 | 0.799927 | 1.599854 | 134 | 7.579102 | 88 | 39 | null | null | 5 |
<2 mo. follow-up
| 5 |
8,529 | 62.35199 | 1 |
female
| 0 | 12 | 94 |
Lung Cancer
|
Cancer
| 1 | 8 | null | 26 | 9,029 | 7,019.7617 | 7,303.75 | 7.5 |
white
| 16.398438 | 25 | 0.628906 | 0.316956 | 1 | 0 | 0 |
metastatic
| 0.3 | 0.1 |
no dnr
| 12 | 70 | 14.798828 | 68 | 14 | 39 | 162.5 | 3.299805 | 0.299988 | 1.199951 | 140 | 7.549805 | 126 | 26 | 2,250 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,530 | 88.20496 | 0 |
male
| 0 | 9 | 1,007 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null |
under $11k
| 0 | 5,190 | 3,528.1582 | 3,333.84961 | 7.5 |
white
| 22.699219 | 32 | 0.733887 | 0.583984 | 1 | 0 | 0 |
no
| 0.75 | 0.5 |
dnr after sadm
| 1 | 54 | 21.097656 | 54 | 36 | 38.79688 | 122.84375 | 3.399902 | 0.5 | 1.599854 | 137 | 7.379883 | 145 | 45 | 1,975 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,531 | 43.80298 | 1 |
male
| 1 | 162 | 162 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 357,329 | 247,808.5 | 261,157.875 | 43.25 |
hispanic
| 39.898438 | 64 | 0.5979 | 0.48999 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
dnr after sadm
| 144 | 113 | 52.898438 | 68 | 28 | 38.29688 | 140 | 3 | 0.399963 | 1 | 136 | 7.359375 | 192 | 49 | 410 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
8,532 | 79.73999 | 0 |
female
| 0 | 29 | 1,005 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 32,877 | 21,715.0469 | 18,913.125 | 11.75 |
white
| 35.59375 | 58 | 0.452942 | 0.333984 | 2 | 0 | 0 |
no
| 0.75 | 0.6 |
no dnr
| 29 | 50 | 10.5 | 138 | 10 | 38.19531 | 124.28125 | 2.199707 | 0.5 | 1.099854 | 142 | 7.399414 | 126 | 28 | 1,925 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,533 | 43.50198 | 0 |
male
| 0 | 28 | 1,002 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 | null | 26 | 115,064 | 74,479.25 | 72,744.3125 | 20.5 |
hispanic
| 28.296875 | 38 | 0.575928 | 0.464966 | 69 | 0 | 0 |
yes
| 0.5 | 0.125 |
no dnr
| 28 | 113 | 7.699219 | 110 | 10 | 38.19531 | 268.5625 | 4 | 0.799927 | 0.599976 | 140 | 7.399414 | 147 | 9 | 2,000 | null | 0 | null | 0 |
8,534 | 77.47296 | 0 |
male
| 0 | 6 | 1,001 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 8 | null | 0 | 4,194 | 2,887.7383 | 2,590.0293 | 11 |
white
| 18 | 25 | 0.846924 | 0.747925 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 6 | 107 | 18.898438 | 64 | 44 | 38.89844 | null | null | null | 0.899902 | 141 | null | 145 | 14 | 2,700 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,535 | 77.36896 | 1 |
male
| 0 | 5 | 825 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 8 |
under $11k
| 0 | 3,151 | 2,127.6445 | 2,010.47949 | 11 |
white
| 17.097656 | 45 | 0.837891 | 0.734985 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 5 | 59 | 7.5 | 72 | 28 | 36.19531 | 266.625 | null | null | 1.699951 | 148 | 7.469727 | 165 | 32 | 2,490 | null | 2 |
adl>=4 (>=5 if sur)
| 2 |
8,536 | 43.362 | 0 |
male
| 0 | 9 | 999 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
$25-$50k
| 9 | 12,516 | 8,738.4375 | 8,641.40625 | 18.5 |
white
| 16.898438 | 26 | 0.901978 | 0.866943 | 3 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 9 | 99 | 11 | 69 | 24 | 36.29688 | 183.3125 | 4.5 | 0.399963 | 0.699951 | 136 | 7.359375 | 157 | 15 | 3,200 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,537 | 54.63699 | 0 |
male
| 0 | 4 | 998 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 9 |
under $11k
| 0 | 9,328 | 5,555.5078 | 5,620.72656 | 16 |
white
| 24.296875 | 28 | 0.844971 | 0.745972 | 1 | 1 | 0 |
no
| 0.5 | 0.2 |
no dnr
| 4 | 102 | 59.59375 | 130 | 36 | 38.29688 | 264 | 3.299805 | 0.399963 | 0.699951 | 133 | 7.439453 | 166 | 10 | 1,105 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
8,538 | 79.33698 | 1 |
female
| 0 | 7 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 44 | 31,978 | 20,569.3281 | 20,135.625 | 25 |
white
| 28.597656 | 73 | 0.368958 | 0.250977 | 8 | 0 | 0 |
no
| 0.25 | 0.1 |
dnr after sadm
| 2 | 69 | null | 79 | 16 | 35.89844 | null | null | null | null | 140 | null | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
8,539 | 76.88196 | 1 |
male
| 0 | 13 | 224 |
Lung Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 8,986 | 6,350.6172 | 6,363.56641 | 3.5 |
hispanic
| 14.398438 | 13 | 0.730957 | 0.459961 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.2 |
dnr after sadm
| 1 | 114 | 30.699219 | 112 | 26 | 36.19531 | 344 | 1.699951 | 1 | 2.199707 | 138 | 7.319336 | 110 | 61 | 3,500 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,540 | 71.22198 | 1 |
male
| 0 | 5 | 506 |
Lung Cancer
|
Cancer
| 1 | 14 |
$11-$25k
| 0 | 5,354 | 3,412.1113 | 2,407.84961 | 5 |
white
| 17.5 | 12 | 0.681885 | 0.386963 | 1 | 0 | 0 |
metastatic
| 1 | 1 |
no dnr
| 5 | 117 | 7.199219 | 73 | 20 | 36.59375 | null | 2.699707 | 0.299988 | 0.699951 | 143 | null | 97 | 5 | 3,410 | null | null |
no(M2 and SIP pres)
| 2.0625 |
8,541 | 66.823 | 1 |
female
| 0 | 35 | 36 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null |
under $11k
| 26 | 135,347 | 89,832.8125 | 92,720 | 40.75 |
white
| 37 | 60 | 0.197998 | 0.105988 | 14 | 0 | 0 |
yes
| 0.2 | 0.2 |
dnr after sadm
| 12 | 84 | 13.699219 | 101 | 8 | 36.29688 | 295.1875 | null | 0.299988 | 0.899902 | 137 | 7.449219 | 150 | 6 | null | null | 1 |
<2 mo. follow-up
| 1 |
8,542 | 70.84698 | 0 |
female
| 0 | 21 | 992 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 | null | 26 | 53,893 | 35,381.0312 | 40,310.5625 | 18.333328 |
hispanic
| 13 | 23 | 0.836914 | 0.781982 | 6 | 1 | 0 |
no
| null | null |
no dnr
| 21 | 55 | 14.298828 | 250 | 24 | 35.79688 | 200 | null | null | 0.899902 | 131 | 7.389648 | 213 | 11 | 2,875 | null | 0 | null | 0 |
8,543 | 71.99695 | 1 |
male
| 0 | 10 | 53 |
Lung Cancer
|
Cancer
| 3 | 8 |
$11-$25k
| 0 | 8,201 | 5,417.3125 | 5,474.62891 | 13 |
white
| 24.5 | 31 | 0.507935 | 0.185974 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.2 |
dnr after sadm
| 1 | 68 | 5.099609 | 122 | 22 | 36.69531 | 290.4375 | null | 0.299988 | 0.599976 | 126 | 7.439453 | 200 | 8 | 2,850 | null | 0 |
<2 mo. follow-up
| 0 |
8,544 | 52.98599 | 1 |
female
| 0 | 8 | 179 |
Colon Cancer
|
Cancer
| 1 | 12 | null | 0 | 7,862 | 4,907.9609 | 4,835.97656 | 13 |
white
| 14.398438 | 15 | 0.865967 | 0.700928 | 1 | 0 | 0 |
metastatic
| 1 | 0.7 |
no dnr
| 8 | 120 | 10.199219 | 20 | 8 | 40.5 | null | null | null | 1 | 134 | null | 235 | 14 | 1,500 | 0 | null | null | 0.494751 |
8,545 | 81.60394 | 1 |
male
| 0 | 6 | 305 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 6 |
under $11k
| 26 | 4,271 | 2,869.4863 | 2,647.35938 | 18 |
white
| 19.5 | 34 | 0.697998 | 0.533936 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
dnr after sadm
| 1 | 114 | 9.699219 | 71 | 24 | 36.39844 | null | null | null | 1.099854 | 134 | null | 189 | 18 | 3,675 | null | null | null | 3.264648 |
8,546 | 69.495 | 0 |
male
| 0 | 17 | 987 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 8 | null | 9 | 49,628 | 33,131.5 | 32,495.4688 | 22 |
white
| 39.796875 | 49 | 0.283997 | 0.174988 | 9 | 0 | 0 |
no
| 0.7 | 0.65 |
no dnr
| 17 | 49 | 7 | 102 | 8 | 38 | 283.3125 | null | null | 0.699951 | 137 | 7.40918 | 252 | 18 | 3,360 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,547 | 79.10199 | 1 |
female
| 0 | 9 | 94 |
Colon Cancer
|
Cancer
| 2 | null | null | 0 | 6,205 | 4,033.4512 | 3,327.06836 | 11 |
white
| 12.398438 | 12 | 0.849976 | 0.668945 | 1 | 1 | 0 |
metastatic
| 0.5 | 0.2 |
dnr before sadm
| -1 | 69 | 8.898438 | 104 | 24 | 36.29688 | null | 3.099609 | 0.299988 | 1.399902 | 134 | null | 104 | 15 | null | null | null | null | 2.558594 |
8,548 | 69.81 | 1 |
female
| 0 | 5 | 149 |
COPD
|
COPD/CHF/Cirrhosis
| 6 | 13 |
under $11k
| 0 | 2,747 | 1,855.1836 | 1,802.7998 | 6 |
white
| 22.5 | 33 | 0.711914 | 0.552979 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.2 |
dnr after sadm
| 1 | 115 | 10.099609 | 72 | 24 | 38.09375 | 115.375 | 3.199707 | 0.5 | 1 | 135 | 7.429688 | 131 | 15 | 2,745 | 2 | null |
no(M2 and SIP pres)
| 1.838867 |
8,549 | 49.66699 | 0 |
female
| 0 | 15 | 986 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
>$50k
| 41 | 19,633 | 13,279.7969 | 13,310.3672 | 15.666664 |
white
| 31.898438 | 39 | 0.554932 | 0.441956 | 2 | 0 | 0 |
no
| 0.85 | 0.8 |
no dnr
| 15 | 61 | 8.298828 | 51 | 24 | 39.19531 | null | 3.299805 | 0.299988 | 0.699951 | 139 | null | 99 | 20 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
8,550 | 36.90298 | 1 |
female
| 0 | 41 | 303 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 0 | 142,705 | 89,958.5625 | 96,921.125 | 41 |
white
| 44.898438 | 81 | 0.052994 | 0.016998 | 14 | 0 | 0 |
metastatic
| 0.3 | 0.2 |
no dnr
| 41 | 107 | 10.5 | 112 | 24 | 36.39844 | 428.5625 | null | null | 1.199951 | 138 | 7.509766 | 115 | 12 | 2,885 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,551 | 20.67899 | 0 |
female
| 0 | 16 | 985 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 18 |
$25-$50k
| 0 | 32,881 | 23,235.1719 | 25,023.4844 | 24 |
hispanic
| 28.597656 | 50 | 0.859985 | 0.810913 | 3 | 0 | 0 |
no
| 0.15 | 0.15 |
no dnr
| 16 | 67 | 9.599609 | 63 | 24 | 38.89844 | 102.03125 | 3.299805 | 0.399963 | 1.799805 | 134 | 7.509766 | 204 | 45 | 3,750 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,552 | 67.35095 | 1 |
male
| 0 | 15 | 105 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 0 | 32,054 | 21,528.0625 | 20,462.25 | 19.333328 |
white
| 24.5 | 42 | 0.751953 | 0.672974 | 5 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 15 | 56 | 20.597656 | 74 | 28 | 36.39844 | 423.75 | 2.799805 | 2.799805 | 1.899902 | 134 | 7.469727 | 128 | 30 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
8,553 | 56.91199 | 0 |
female
| 0 | 6 | 983 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$25-$50k
| 0 | 4,438 | 3,007.2383 | 2,494.47852 | 8 |
white
| 20.796875 | 14 | 0.875 | 0.792969 | 1 | 1 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 6 | 66 | 0.399963 | 136 | 26 | 35.59375 | 174.28125 | 2.5 | 0.599976 | 2.299805 | 144 | 7.359375 | 235 | 47 | 2,355 | 2 | null |
no(M2 and SIP pres)
| 1.838867 |
8,554 | 89.88397 | 1 |
male
| 0 | 5 | 439 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 8 |
under $11k
| 0 | 2,318 | 1,608.4033 | 1,264.22949 | 8 |
white
| 21 | 40 | 0.756958 | 0.61499 | 1 | 0 | 0 |
no
| 0.95 | 0.6 |
dnr after sadm
| 1 | 61 | null | 96 | 20 | 36.39844 | null | null | null | null | 140 | null | null | null | 2,800 | null | 1 |
no(M2 and SIP pres)
| 1 |
8,555 | 65.99298 | 0 |
female
| 0 | 30 | 982 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 118,602 | 78,316 | 74,614.5625 | 20.75 |
white
| 30.199219 | 42 | 0.594971 | 0.485962 | 29 | 1 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 30 | 98 | 4.199219 | 76 | 20 | 37 | null | 2.599609 | 1.599854 | 1.199951 | 136 | null | 124 | 10 | null | null | null | null | 2.907227 |
8,556 | 71.98395 | 1 |
male
| 0 | 45 | 309 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 | null | 0 | 96,019 | 63,468.125 | 59,092.8438 | 21.75 |
white
| 20.398438 | 26 | 0.741943 | 0.661987 | 7 | 1 | 0 |
yes
| 0.9 | 0.9 |
no dnr
| 45 | 115 | 10.5 | 74 | 22 | 38.09375 | 112.5 | null | null | 1.699951 | 137 | 7.429688 | 115 | 17 | 2,095 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,557 | 80.53894 | 0 |
female
| 0 | 7 | 976 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null |
$11-$25k
| 9 | 5,578 | 3,624.8731 | 4,191.1875 | 7 |
white
| 16.5 | 32 | 0.806885 | 0.688965 | 1 | 0 | 1 |
no
| 0.9 | 0.7 |
dnr after sadm
| 1 | 129 | 15.099609 | 136 | 28 | 39.39844 | 106 | 2.599609 | 0.699951 | 5.199219 | 144 | 7.359375 | 118 | 60 | 1,540 | null | 2 |
no(M2 and SIP pres)
| 2 |
8,558 | 67.74799 | 1 |
male
| 0 | 13 | 22 |
Lung Cancer
|
Cancer
| 1 | 20 | null | 37 | 8,261 | 5,839.0312 | 5,178.41797 | 4.5 |
hispanic
| 21.5 | 24 | 0.419983 | 0.116989 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 1 | 71 | 11.199219 | 101 | 20 | 36.19531 | null | 3.299805 | 0.399963 | 0.799927 | 139 | null | 154 | 12 | 3,000 | null | null |
<2 mo. follow-up
| 3.527344 |
8,559 | 34.491 | 1 |
female
| 0 | 7 | 10 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 9,067 | 6,019.6328 | 6,112.64844 | 6.5 |
hispanic
| 27.097656 | 38 | 0.557983 | 0.235992 | 1 | 0 | 0 |
metastatic
| 0.05 | 0 |
dnr after sadm
| 7 | 103 | 9.099609 | 63 | 36 | 36 | 216 | 4 | 0.899902 | 1.199951 | 136 | 7.369141 | 136 | 21 | null | null | 3 |
<2 mo. follow-up
| 3 |
8,560 | 76.36694 | 1 |
male
| 0 | 11 | 47 |
Lung Cancer
|
Cancer
| 1 | 8 |
$11-$25k
| 0 | 13,244 | 9,110.2578 | 6,189.46875 | 10.5 |
white
| 20.699219 | 19 | 0.594971 | 0.27594 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.25 |
no dnr
| 11 | 109 | 10.398438 | 126 | 36 | 38.29688 | 192 | null | null | 0.699951 | 139 | 7.55957 | 256 | 25 | 5,450 | null | 1 |
<2 mo. follow-up
| 1 |
8,561 | 74.43097 | 0 |
male
| 0 | 12 | 973 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 | null | 0 | 9,343 | 6,462.2656 | 5,127.62891 | 5.5 |
white
| 24.398438 | 27 | 0.768921 | 0.631958 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr before sadm
| -1 | 56 | 17.699219 | 136 | 30 | 38.69531 | 420.375 | 2.199707 | 1.599854 | 1.199951 | 135 | 7.40918 | 183 | 19 | 2,125 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,562 | 86.63397 | 1 |
male
| 0 | 4 | 335 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 8 |
under $11k
| 0 | 2,045 | 1,430.6904 | 1,166.73926 | 6 |
white
| 16.796875 | 25 | 0.830933 | 0.723999 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
dnr before sadm
| -1 | 71 | 11 | 200 | 22 | 36.19531 | null | 3.899902 | 0.399963 | 1.399902 | 136 | null | 119 | 24 | 3,180 | 2 | 0 |
no(M2 and SIP pres)
| 0 |
8,563 | 55.22498 | 1 |
male
| 0 | 3 | 161 |
Lung Cancer
|
Cancer
| 1 | 8 | null | 0 | 1,169 | 768.2168 | 836.09961 | null |
white
| 12.898438 | 11 | 0.79895 | 0.572998 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.4 |
no dnr
| 3 | 100 | 6.099609 | 70 | 40 | 37.59375 | 192 | null | null | 2.199707 | 138 | 7.319336 | 252 | 52 | 1,805 | 2 | null |
no(M2 and SIP pres)
| 1.838867 |
8,564 | 66.56494 | 0 |
male
| 0 | 14 | 971 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 9 | 14,408 | 9,784.1094 | 9,323.80469 | 11 |
white
| 32.195313 | 25 | 0.625 | 0.440979 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
dnr after sadm
| 8 | 66 | 13 | 60 | 28 | 35.59375 | null | 3.899902 | 0.799927 | 2.199707 | 142 | null | 129 | 31 | 2,250 | null | 0 | null | 0 |
8,565 | 55.82498 | 0 |
female
| 0 | 5 | 970 |
Lung Cancer
|
Cancer
| 1 | 14 |
>$50k
| 0 | 8,226 | 5,446.2383 | 5,091.07812 | 6 |
white
| 18.699219 | 6 | 0.695923 | 0.407959 | 1 | 0 | 0 |
metastatic
| 0.98 | 0.95 |
no dnr
| 5 | 68 | 7.299805 | 59 | 24 | 35.79688 | 336 | 4.199219 | 1.799805 | 1.699951 | 139 | 7.449219 | 165 | 31 | 1,150 | null | null | null | 2.08252 |
8,566 | 83.64099 | 1 |
male
| 0 | 56 | 628 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 9 |
under $11k
| 0 | 56,792 | 35,551.625 | 33,132.6875 | 11.5 |
white
| 13.398438 | 11 | 0.813965 | 0.698975 | 1 | 0 | 0 |
yes
| 0.5 | 0.5 |
dnr before sadm
| 0 | 96 | null | 69 | 20 | 36.89844 | null | null | null | null | 140 | null | null | null | 2,950 | 0 | 0 |
SIP>=30
| 0 |
8,567 | 77.28998 | 1 |
male
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 9 | 72,115 | 47,257.7188 | 47,797.5 | 41.666657 |
white
| 33.195313 | 67 | 0.521973 | 0.405945 | 1 | 0 | 0 |
no
| 0.25 | 0.25 |
dnr after sadm
| 1 | 61 | 7.399414 | 70 | 20 | 36.29688 | 309.5 | 4.299805 | 0.299988 | 1.199951 | 138 | 7.419922 | 124 | 14 | 1,450 | null | 0 |
<2 mo. follow-up
| 0 |
8,568 | 85.68695 | 1 |
female
| 0 | 7 | 276 |
CHF
|
COPD/CHF/Cirrhosis
| 6 | 15 | null | 26 | 6,017 | 4,248.1484 | 3,629.04883 | 10.5 |
white
| 22.398438 | 22 | 0.659912 | 0.484985 | 1 | 0 | 1 |
no
| 0.2 | 0.5 |
no dnr
| 7 | 101 | 7.899414 | 72 | 24 | 36.09375 | 252.375 | null | null | 1.199951 | 138 | 7.319336 | 133 | 17 | null | null | 4 |
adl>=4 (>=5 if sur)
| 4 |
8,569 | 82.97095 | 1 |
male
| 1 | 21 | 21 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 16 | null | 0 | 36,986 | 25,526.625 | 24,256.0312 | 22.333328 |
white
| 24.898438 | 36 | 0.630981 | 0.447998 | 3 | 0 | 0 |
no
| 0.8 | 0.65 |
dnr after sadm
| 21 | 53 | 5.699219 | 120 | 10 | 38 | 130 | 4 | 0.5 | 0.899902 | 131 | 7.439453 | 148 | 11 | 2,320 | null | null |
<2 mo. follow-up
| 3.151367 |
8,570 | 43.38898 | 0 |
female
| 0 | 14 | 968 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 0 | 30,170 | 21,486.7188 | 19,866.8125 | 19.333328 |
white
| 25.796875 | 50 | 0.849976 | 0.797974 | 1 | 1 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 14 | 110 | 12 | 72 | 28 | 35.69531 | 108.15625 | null | null | 2.599609 | 134 | 7.339844 | 144 | 33 | 1,630 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,571 | 70.76495 | 1 |
male
| 0 | 7 | 33 |
Coma
|
Coma
| 2 | 8 | null | 0 | 8,484 | 5,791.332 | 6,613.83984 | 2 |
white
| 16.796875 | 19 | 0.669922 | 0.612915 | 1 | 1 | 0 |
metastatic
| 0.2 | 0.1 |
dnr after sadm
| 1 | 71 | null | 65 | 25 | 38.09375 | null | 3.099609 | 0.599976 | 1.299805 | 141 | null | 157 | 14 | 800 | null | 6 |
<2 mo. follow-up
| 6 |
8,572 | 27.63899 | 0 |
male
| 0 | 39 | 964 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 0 | 83,491 | 62,021.4062 | 64,970.2812 | 36 |
white
| 32 | 62 | 0.740967 | 0.658936 | 4 | 1 | 0 |
yes
| 0.5 | 0.45 |
no dnr
| 39 | 123 | 10.699219 | 60 | 24 | 36.39844 | 244 | 3.699707 | 0.699951 | 1.399902 | 136 | 7.389648 | 110 | 18 | 2,200 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,573 | 75.21399 | 0 |
female
| 0 | 26 | 963 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 18 | null | 61 | 28,177 | 19,605.7812 | 19,261.5469 | 12.25 |
white
| 20.597656 | 20 | 0.414978 | 0.294983 | 1 | 0 | 0 |
metastatic
| 0.3 | 0.25 |
dnr after sadm
| 8 | 71 | 9.298828 | 98 | 24 | 36.79688 | 218.5 | null | null | 0.899902 | 141 | 7.359375 | 117 | 20 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
8,574 | 64.159 | 1 |
female
| 0 | 29 | 46 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5 | 7 | null | 0 | 65,508 | 45,789.5 | 41,963.4062 | 15.25 |
white
| 35.59375 | 83 | 0.259949 | 0.095993 | 23 | 1 | 0 |
no
| 0.5 | 0.2 |
dnr after sadm
| 2 | 39 | 46.09375 | 54 | 28 | 40.09375 | 200 | 3.299805 | 1.299805 | 1 | 130 | 7.369141 | 143 | 53 | null | null | 5 |
<2 mo. follow-up
| 5 |
8,575 | 29.32199 | 0 |
male
| 0 | 14 | 962 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
under $11k
| 0 | 61,935 | 40,505.625 | 44,229.25 | 16.333328 |
white
| 23.296875 | 62 | 0.880981 | 0.838989 | 6 | 0 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 14 | 59 | 19.199219 | 155 | 30 | 38.79688 | 217.5 | 2.099609 | 3 | 1.699951 | 144 | 7.519531 | 352 | 67 | 670 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,576 | 78.49097 | 1 |
female
| 0 | 16 | 45 |
Colon Cancer
|
Cancer
| 1 | 8 |
$11-$25k
| 0 | 17,797 | 11,066.9062 | 10,606.2578 | 10.333328 |
white
| 23.796875 | 19 | 0.664917 | 0.362976 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.7 |
dnr after sadm
| 2 | 135 | 13.599609 | 130 | 24 | 36.39844 | 267.5 | 2.899902 | 19.296875 | 3.299805 | 136 | 7.439453 | 104 | 39 | 8 | 1 | 1 |
<2 mo. follow-up
| 1 |
8,577 | 77.80695 | 1 |
female
| 0 | 11 | 270 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | 9 |
under $11k
| 9 | 7,835 | 5,073.3906 | 4,911.55859 | 10 |
white
| 16.796875 | 29 | 0.819946 | 0.707886 | 1 | 0 | 1 |
no
| 0.75 | 0.5 |
dnr after sadm
| 1 | 61 | 10.699219 | 65 | 22 | 35.19531 | null | 4 | 0.899902 | 1.899902 | 134 | null | 119 | 40 | 2,050 | null | 2 |
no(M2 and SIP pres)
| 2 |
8,578 | 64.14197 | 1 |
male
| 0 | 29 | 32 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 | null | 0 | 29,101 | 24,080.6406 | 17,077.8281 | 10.5 |
white
| 32.796875 | 57 | 0.662964 | 0.487976 | 1 | 0 | 0 |
no
| 0.6 | 0.2 |
dnr after sadm
| 1 | 129 | 11.599609 | 160 | 26 | 35.59375 | 180 | null | null | 1.099854 | 136 | 7.359375 | 125 | 16 | 1,165 | 0 | 1 |
<2 mo. follow-up
| 1 |
8,579 | 71.83795 | 1 |
male
| 0 | 13 | 575 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 8 | null | 0 | 18,689 | 13,812.0234 | 12,418.1562 | 21.5 |
white
| 23 | 48 | 0.789917 | 0.662964 | 1 | 1 | 0 |
no
| 0.8 | 0.5 |
dnr after sadm
| 7 | 66 | 4.199219 | 62 | 16 | 36.09375 | 368 | 2.899902 | 0.899902 | 1.199951 | 140 | 7.40918 | 106 | 12 | 570 | null | 1 | null | 1 |
8,580 | 72.91998 | 0 |
male
| 0 | 4 | 953 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 10 |
under $11k
| 0 | 2,772 | 1,852.792 | 1,598.87988 | 9 |
white
| 20.199219 | 32 | 0.793945 | 0.668945 | 1 | 0 | 0 |
yes
| 0.9 | 0.5 |
dnr after sadm
| 1 | 128 | 8.599609 | 66 | 32 | 36.5 | 257.125 | 3.899902 | 0.5 | 0.899902 | 137 | 7.369141 | 122 | 16 | 1,725 | 3 | 1 |
no(M2 and SIP pres)
| 1 |
8,581 | 72.58295 | 0 |
male
| 0 | 10 | 951 |
Coma
|
Coma
| 1 | 8 |
under $11k
| 44 | 26,865 | 17,952.7344 | 16,961.9844 | 20.5 |
white
| 24 | 32 | 0.334961 | 0.261963 | 6 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 10 | 97 | 13.398438 | 114 | 20 | 36 | null | 4 | 0.799927 | 0.899902 | 133 | null | 163 | 17 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
8,582 | 64.89294 | 1 |
male
| 0 | 18 | 24 |
Colon Cancer
|
Cancer
| 3 | 12 |
under $11k
| 0 | 18,815 | 12,221.5391 | 13,080.2578 | 9.666664 |
white
| 26.898438 | 36 | 0.635986 | 0.325989 | 1 | 0 | 0 |
metastatic
| 0.25 | 0.1 |
dnr after sadm
| 3 | 66 | 13.798828 | 122 | 36 | 36.39844 | 232.5 | null | null | 0.5 | 129 | 7.469727 | 115 | 14 | 1,950 | 0 | 0 |
<2 mo. follow-up
| 0 |
8,583 | 75.33698 | 1 |
female
| 0 | 3 | 269 |
Lung Cancer
|
Cancer
| 1 | 12 |
under $11k
| 0 | 3,367 | 1,993.8936 | 999.34961 | null |
white
| 17.398438 | 7 | 0.674927 | 0.377991 | 1 | 0 | 0 |
metastatic
| 1 | 1 |
no dnr
| 3 | 63 | 7.599609 | 120 | 16 | 38.29688 | null | 3.599609 | 0.699951 | 1.099854 | 140 | null | 105 | 11 | 1,335 | null | 1 | null | 1 |
8,584 | 80.698 | 1 |
female
| 0 | 7 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 |
>$50k
| 44 | 15,560 | 10,941.5469 | 10,315.4844 | 12.5 |
white
| 29.296875 | 52 | 0.367981 | 0.250977 | 4 | 0 | 0 |
no
| 0.05 | 0 |
dnr after sadm
| 2 | 79 | null | 77 | 24 | 36.29688 | null | null | null | null | 140 | null | null | null | 2,550 | null | 2 |
<2 mo. follow-up
| 2 |
8,585 | 78.62299 | 1 |
female
| 0 | 7 | 294 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 5 |
under $11k
| 0 | 5,117 | 3,498.4219 | 3,653.75977 | 4 |
white
| 18.5 | 39 | 0.836914 | 0.73291 | 1 | 0 | 0 |
no
| 0.7 | 0.5 |
dnr after sadm
| 3 | 65 | 5.799805 | 100 | 28 | 36.5 | 276.1875 | 2.5 | 3.599609 | 0.799927 | 135 | 7.5 | 84 | 9 | 1,050 | null | 5 |
adl>=4 (>=5 if sur)
| 5 |
8,586 | 72.48999 | 1 |
male
| 0 | 19 | 247 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 14 | null | 0 | 37,936 | 25,669.4531 | 27,133.8438 | 30.333328 |
white
| 26.199219 | 42 | 0.726929 | 0.642944 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 1 | 78 | 10.699219 | 62 | 20 | 35.69531 | 319 | null | null | 1.099854 | 136 | 7.509766 | 131 | 18 | 1,200 | null | 1 |
no(M2 and SIP pres)
| 1 |
8,587 | 72.51495 | 1 |
female
| 0 | 5 | 167 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 10 | null | 0 | 3,035 | 2,042.083 | 2,346.17969 | 9 |
white
| 21.296875 | 23 | 0.727905 | 0.574951 | 1 | 0 | 0 |
metastatic
| 1 | 0.9 |
no dnr
| 5 | 103 | 2.899902 | 67 | 36 | 36.39844 | 309.5 | 4.299805 | 0.699951 | 1 | 138 | 7.469727 | 140 | 11 | null | 1 | null |
adl>=4 (>=5 if sur)
| 1.166748 |
8,588 | 74.54297 | 1 |
male
| 0 | 6 | 334 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
$11-$25k
| 0 | 4,039 | 2,884.7246 | 2,318.85938 | 13 |
white
| 19.398438 | 40 | 0.839966 | 0.736938 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
dnr after sadm
| 1 | 58 | 10.5 | 70 | 12 | 38.5 | 160 | 2.099609 | 0.699951 | 0.599976 | 134 | 7.469727 | 106 | 9 | 2,990 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
8,589 | 84.68695 | 1 |
male
| 0 | 11 | 142 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 10 |
$11-$25k
| 0 | 9,362 | 6,366.5742 | 5,481.01953 | 9.5 |
white
| 23.296875 | 37 | 0.68689 | 0.519897 | 1 | 0 | 0 |
no
| 0.9 | 0.65 |
dnr after sadm
| 1 | 61 | 0.699951 | 136 | 30 | 38.59375 | 153.3125 | 3.399902 | 0.299988 | 3.199707 | 133 | 7.329102 | 137 | 52 | 5,225 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
8,590 | 73.25397 | 1 |
female
| 0 | 8 | 664 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 8 | null | 0 | 7,249 | 5,278.793 | 4,973.81641 | 8 |
white
| 20.097656 | 26 | 0.834961 | 0.72998 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 8 | 71 | null | 98 | 24 | 36.09375 | 180.9375 | 4.5 | 0.299988 | 1.399902 | 143 | 7.369141 | 179 | 28 | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
8,591 | 70.01196 | 1 |
female
| 0 | 11 | 237 |
Coma
|
Coma
| 2 | null | null | 0 | 17,659 | 11,679.6562 | 11,399.0078 | 16 |
white
| 16.699219 | 25 | 0.622925 | 0.559937 | 5 | 0 | 0 |
metastatic
| 0.25 | 0.2 |
no dnr
| 11 | 109 | 5.5 | 67 | 22 | 36.39844 | null | 3.399902 | 0.299988 | 0.599976 | 133 | null | 119 | 13 | 3,000 | null | null | null | 2.575684 |
8,592 | 51.11298 | 1 |
male
| 0 | 4 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 10 |
under $11k
| 0 | 15,226 | 10,579.2344 | 11,855.9922 | 43 |
white
| 23.296875 | 45 | 0.856934 | 0.806885 | 1 | 0 | 0 |
no
| 0 | 0 |
dnr after sadm
| 3 | 122 | 8.398438 | 116 | 40 | 36.39844 | 240 | 3.699707 | 0.599976 | 0.699951 | 131 | 7.30957 | 154 | 7 | 1,905 | 2 | null |
<2 mo. follow-up
| 1.838867 |
8,593 | 74.39294 | 1 |
male
| 0 | 6 | 38 |
Colon Cancer
|
Cancer
| 1 | 12 |
under $11k
| 0 | 4,666 | 3,002.5547 | 3,108.58984 | 10 |
white
| 32.695313 | 28 | 0.448975 | 0.136993 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 6 | 73 | 7.399414 | 52 | 24 | 35.69531 | null | 3.399902 | 0.299988 | 2.599609 | 135 | null | 122 | 81 | 2,275 | 0 | 0 |
<2 mo. follow-up
| 0 |
8,594 | 80.55896 | 1 |
male
| 0 | 7 | 86 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 4,963 | 3,264.0234 | 4,021.99805 | 5 |
white
| 21.796875 | 24 | 0.748901 | 0.603882 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 7 | 73 | 6.599609 | 65 | 16 | 35.69531 | 309.5 | 4.099609 | 0.399963 | 1.5 | 136 | 7.359375 | 97 | 24 | 2,075 | 5 | 5 |
adl>=4 (>=5 if sur)
| 5 |
8,595 | 51.25 | 1 |
female
| 0 | 29 | 310 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 11 |
$11-$25k
| 37 | 114,515 | 73,225.1875 | 74,234.25 | 40.75 |
white
| 45.695313 | 102 | 0.011999 | 0.002 | 10 | 0 | 0 |
yes
| 0.6 | 0.55 |
no dnr
| 29 | 63 | 6.799805 | 73 | 18 | 37 | null | 4.399414 | 0.699951 | 1.199951 | 137 | null | 95 | 3 | 3,000 | null | 0 |
no(M2 and SIP pres)
| 0 |
8,596 | 79.90997 | 0 |
male
| 0 | 30 | 937 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 6 |
under $11k
| 0 | 65,546 | 46,235.5938 | 42,307.9375 | 23.75 |
white
| 31.199219 | 51 | 0.533936 | 0.418945 | 5 | 1 | 0 |
no
| 0.8 | 0.7 |
dnr after sadm
| 15 | 59 | 12 | 70 | 24 | 35.39844 | 409.5 | null | null | 2 | 132 | 7.539062 | 102 | 45 | 1,725 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
8,597 | 86.80896 | 1 |
male
| 0 | 74 | 891 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 | null | 37 | 197,774 | 131,938.75 | 129,221.25 | 33.5 |
white
| 27.097656 | 42 | 0.274963 | 0.166992 | 23 | 0 | 0 |
yes
| 0.05 | 0.01 |
dnr after sadm
| 3 | 63 | 4.599609 | 112 | 52 | 38.59375 | 133.3125 | 2.599609 | 0.199982 | 0.699951 | 134 | 7.519531 | 139 | 4 | 6,500 | null | 0 |
Coma or Intub
| 0 |
8,598 | 70.09698 | 0 |
female
| 0 | 149 | 936 |
Coma
|
Coma
| 4 | 8 |
$11-$25k
| 41 | 254,992 | 191,685.625 | 189,225 | 27.5 |
white
| 22.898438 | 61 | 0.27594 | 0.20697 | 22 | 1 | 0 |
yes
| 0.3 | 0.3 |
no dnr
| 149 | 97 | 78.796875 | 112 | 30 | 35.89844 | 146.125 | null | null | 1.5 | 142 | 7.319336 | 326 | 39 | 1,440 | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
8,599 | 75.67999 | 1 |
male
| 0 | 8 | 9 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 | null | 44 | 41,646 | 28,043.875 | 27,575.7812 | 37.5 |
white
| 26.5 | 41 | 0.475952 | 0.357971 | 5 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 8 | 104 | 7.099609 | 107 | 24 | 36.09375 | null | 4.199219 | 0.699951 | 1.299805 | 136 | null | 235 | 14 | null | null | 0 |
<2 mo. follow-up
| 0 |
8,600 | 68.14197 | 1 |
male
| 0 | 25 | 34 |
Lung Cancer
|
Cancer
| 1 | 12 | null | 0 | 29,137 | 19,464.4375 | 20,280.7656 | 3.75 |
white
| 23.199219 | 32 | 0.554932 | 0.232971 | 1 | 0 | 0 |
metastatic
| 1 | 1 |
dnr after sadm
| 14 | 117 | 46.695313 | 156 | 11 | 39.79688 | 205.6875 | null | null | 0.699951 | 148 | 7.439453 | 173 | 26 | 4,000 | 4 | 3 |
<2 mo. follow-up
| 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.